ANN HEMATOL 润色咨询

ANNALS OF HEMATOLOGY

出版年份:1991 年文章数:2290 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:5.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2197970, encodeId=2f3a219e970d7, content=质量检查就10天了,崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bbb4799156, createdName=2606467171, createdTime=Thu Apr 11 13:43:26 CST 2024, time=2024-04-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=577471, encodeId=68545e74718d, content=我也<span class="quote">130****6528 2019-10-03 00:00:00 发表:<br>With editor已经三个月了,想撤稿</span>, beContent=130****6528 2019-10-03 00:00:00 发表: With editor已经三个月了,想撤稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17c95089935, createdName=145cf120m10(暂无昵称), createdTime=Tue Oct 08 00:00:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243217, encodeId=14cd224321ecb, content=偏重的研究方向:白血病<br>经验分享:投了两篇letter,2个月了还是显示with editor ,求教各位大神正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Wed Dec 18 06:28:28 CST 2024, time=2024-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241787, encodeId=43762241e8705, content=我的投稿从系统里消失了,前几天还好好的,已经送外审了,从昨天点进去一看根本找不到我的文章了,也没有任何被拒的痕迹或者邮件,而且好像springer nature下的各期刊都没有自己的主页,所以我找不到annals of hematology可以联系的邮箱,大家有遇到过这种情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f218759120, createdName=ms3000001014938846, createdTime=Wed Dec 11 09:58:30 CST 2024, time=2024-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2237488, encodeId=1155223e488ce, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:临床研究;移植预处理方案;前瞻,2期,单臂研究<br>经验分享:前期经过5次拒稿,我2024年1月14投稿Annals of hematology,2024年1月31编辑审核后送外审,2024年7月10日收到修改意见,2024年8月23收到文章被接受的消息,9月份线上发表,11月正式见刊,真的很开心,文章的顺利接受也带给我了信心,让我继续完成第二篇文章的创作,期待好的结果,也希望把这份好运气带给每一位投稿人,不管什么时候都不要放弃,你的文章一定会有属于它的一个家会接收它!加油,williamhill asia 都很棒!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/53b4a1217f3a4e079e3eaf104e804c09-leSA8mUKFk8P.jpg, createdBy=d5908847710, createdName=ms4000000203499871, createdTime=Sun Nov 17 22:09:53 CST 2024, time=2024-11-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183703, encodeId=792f2183e038c, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:投白血病相关的综述,2个审稿人,提的意见比较中肯,审稿速度很快<br>2023-11-23 投稿<br>2023-11-28 editor assigned<br>2023-11-29 Under Review<br>2023-12-12 Major revision<br>2023-12-26 Submitted to journal<br>2023-12-27 Under Review<br>2024-01-15 minor revision<br>2024-01-16 Submitted to journal<br>2024-01-19 Submission accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=775c5640894, createdName=ms8000000428100640, createdTime=Wed Jan 24 16:20:42 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;血液病<br>经验分享:根据投稿威廉亚洲博彩公司 要求修改排版,表达准确,图表清晰度够,审稿快,通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受 编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926986, encodeId=b5b192698693, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2020-09-04 投稿<br>2020-09-10 with editor<br>2020-10-02 Under Review<br>2020-11-11 Major Revision<br>2021-02-01 大修返回去<br>2021-02-02 with editor<br>2021-02-24 Accept<br>两个审稿人,大约提了20个问题,许多都是williamhill asia 当时刻意回避的,审稿人都提出来了,在大修中认真回答审稿人的问题,让做亚组分析就做亚组分析,不能补充的内容就实话实说,告知审稿人williamhill asia 的困难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLfmR4mafTv9yhHTykjCcGOQP5acHwbYj07fiaDoT6p8jxes2icO8n9R8BD8t0LJmg1SjlPiaqWZn33g/132, createdBy=5c971339316, createdName=bright120, createdTime=Wed Feb 24 23:39:35 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了,一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=)]
    2024-04-11 2606467171 来自四川省

    质量检查就10天了,崩溃

    6

    展开6条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2197970, encodeId=2f3a219e970d7, content=质量检查就10天了,崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bbb4799156, createdName=2606467171, createdTime=Thu Apr 11 13:43:26 CST 2024, time=2024-04-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=577471, encodeId=68545e74718d, content=我也<span class="quote">130****6528 2019-10-03 00:00:00 发表:<br>With editor已经三个月了,想撤稿</span>, beContent=130****6528 2019-10-03 00:00:00 发表: With editor已经三个月了,想撤稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17c95089935, createdName=145cf120m10(暂无昵称), createdTime=Tue Oct 08 00:00:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243217, encodeId=14cd224321ecb, content=偏重的研究方向:白血病<br>经验分享:投了两篇letter,2个月了还是显示with editor ,求教各位大神正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Wed Dec 18 06:28:28 CST 2024, time=2024-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241787, encodeId=43762241e8705, content=我的投稿从系统里消失了,前几天还好好的,已经送外审了,从昨天点进去一看根本找不到我的文章了,也没有任何被拒的痕迹或者邮件,而且好像springer nature下的各期刊都没有自己的主页,所以我找不到annals of hematology可以联系的邮箱,大家有遇到过这种情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f218759120, createdName=ms3000001014938846, createdTime=Wed Dec 11 09:58:30 CST 2024, time=2024-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2237488, encodeId=1155223e488ce, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:临床研究;移植预处理方案;前瞻,2期,单臂研究<br>经验分享:前期经过5次拒稿,我2024年1月14投稿Annals of hematology,2024年1月31编辑审核后送外审,2024年7月10日收到修改意见,2024年8月23收到文章被接受的消息,9月份线上发表,11月正式见刊,真的很开心,文章的顺利接受也带给我了信心,让我继续完成第二篇文章的创作,期待好的结果,也希望把这份好运气带给每一位投稿人,不管什么时候都不要放弃,你的文章一定会有属于它的一个家会接收它!加油,williamhill asia 都很棒!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/53b4a1217f3a4e079e3eaf104e804c09-leSA8mUKFk8P.jpg, createdBy=d5908847710, createdName=ms4000000203499871, createdTime=Sun Nov 17 22:09:53 CST 2024, time=2024-11-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183703, encodeId=792f2183e038c, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:投白血病相关的综述,2个审稿人,提的意见比较中肯,审稿速度很快<br>2023-11-23 投稿<br>2023-11-28 editor assigned<br>2023-11-29 Under Review<br>2023-12-12 Major revision<br>2023-12-26 Submitted to journal<br>2023-12-27 Under Review<br>2024-01-15 minor revision<br>2024-01-16 Submitted to journal<br>2024-01-19 Submission accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=775c5640894, createdName=ms8000000428100640, createdTime=Wed Jan 24 16:20:42 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;血液病<br>经验分享:根据投稿威廉亚洲博彩公司 要求修改排版,表达准确,图表清晰度够,审稿快,通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受 编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926986, encodeId=b5b192698693, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2020-09-04 投稿<br>2020-09-10 with editor<br>2020-10-02 Under Review<br>2020-11-11 Major Revision<br>2021-02-01 大修返回去<br>2021-02-02 with editor<br>2021-02-24 Accept<br>两个审稿人,大约提了20个问题,许多都是williamhill asia 当时刻意回避的,审稿人都提出来了,在大修中认真回答审稿人的问题,让做亚组分析就做亚组分析,不能补充的内容就实话实说,告知审稿人williamhill asia 的困难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLfmR4mafTv9yhHTykjCcGOQP5acHwbYj07fiaDoT6p8jxes2icO8n9R8BD8t0LJmg1SjlPiaqWZn33g/132, createdBy=5c971339316, createdName=bright120, createdTime=Wed Feb 24 23:39:35 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了,一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=)]
    2019-10-08 145cf120m10(暂无昵称)

    我也130****6528 2019-10-03 00:00:00 发表:
    With editor已经三个月了,想撤稿

    130****6528 2019-10-03 00:00:00 发表: With editor已经三个月了,想撤稿

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2197970, encodeId=2f3a219e970d7, content=质量检查就10天了,崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bbb4799156, createdName=2606467171, createdTime=Thu Apr 11 13:43:26 CST 2024, time=2024-04-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=577471, encodeId=68545e74718d, content=我也<span class="quote">130****6528 2019-10-03 00:00:00 发表:<br>With editor已经三个月了,想撤稿</span>, beContent=130****6528 2019-10-03 00:00:00 发表: With editor已经三个月了,想撤稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17c95089935, createdName=145cf120m10(暂无昵称), createdTime=Tue Oct 08 00:00:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243217, encodeId=14cd224321ecb, content=偏重的研究方向:白血病<br>经验分享:投了两篇letter,2个月了还是显示with editor ,求教各位大神正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Wed Dec 18 06:28:28 CST 2024, time=2024-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241787, encodeId=43762241e8705, content=我的投稿从系统里消失了,前几天还好好的,已经送外审了,从昨天点进去一看根本找不到我的文章了,也没有任何被拒的痕迹或者邮件,而且好像springer nature下的各期刊都没有自己的主页,所以我找不到annals of hematology可以联系的邮箱,大家有遇到过这种情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f218759120, createdName=ms3000001014938846, createdTime=Wed Dec 11 09:58:30 CST 2024, time=2024-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2237488, encodeId=1155223e488ce, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:临床研究;移植预处理方案;前瞻,2期,单臂研究<br>经验分享:前期经过5次拒稿,我2024年1月14投稿Annals of hematology,2024年1月31编辑审核后送外审,2024年7月10日收到修改意见,2024年8月23收到文章被接受的消息,9月份线上发表,11月正式见刊,真的很开心,文章的顺利接受也带给我了信心,让我继续完成第二篇文章的创作,期待好的结果,也希望把这份好运气带给每一位投稿人,不管什么时候都不要放弃,你的文章一定会有属于它的一个家会接收它!加油,williamhill asia 都很棒!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/53b4a1217f3a4e079e3eaf104e804c09-leSA8mUKFk8P.jpg, createdBy=d5908847710, createdName=ms4000000203499871, createdTime=Sun Nov 17 22:09:53 CST 2024, time=2024-11-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183703, encodeId=792f2183e038c, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:投白血病相关的综述,2个审稿人,提的意见比较中肯,审稿速度很快<br>2023-11-23 投稿<br>2023-11-28 editor assigned<br>2023-11-29 Under Review<br>2023-12-12 Major revision<br>2023-12-26 Submitted to journal<br>2023-12-27 Under Review<br>2024-01-15 minor revision<br>2024-01-16 Submitted to journal<br>2024-01-19 Submission accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=775c5640894, createdName=ms8000000428100640, createdTime=Wed Jan 24 16:20:42 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;血液病<br>经验分享:根据投稿威廉亚洲博彩公司 要求修改排版,表达准确,图表清晰度够,审稿快,通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受 编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926986, encodeId=b5b192698693, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2020-09-04 投稿<br>2020-09-10 with editor<br>2020-10-02 Under Review<br>2020-11-11 Major Revision<br>2021-02-01 大修返回去<br>2021-02-02 with editor<br>2021-02-24 Accept<br>两个审稿人,大约提了20个问题,许多都是williamhill asia 当时刻意回避的,审稿人都提出来了,在大修中认真回答审稿人的问题,让做亚组分析就做亚组分析,不能补充的内容就实话实说,告知审稿人williamhill asia 的困难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLfmR4mafTv9yhHTykjCcGOQP5acHwbYj07fiaDoT6p8jxes2icO8n9R8BD8t0LJmg1SjlPiaqWZn33g/132, createdBy=5c971339316, createdName=bright120, createdTime=Wed Feb 24 23:39:35 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了,一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=)]
    2024-12-18 wylj

    偏重的研究方向:白血病
    经验分享:投了两篇letter,2个月了还是显示with editor ,求教各位大神正常吗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2197970, encodeId=2f3a219e970d7, content=质量检查就10天了,崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bbb4799156, createdName=2606467171, createdTime=Thu Apr 11 13:43:26 CST 2024, time=2024-04-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=577471, encodeId=68545e74718d, content=我也<span class="quote">130****6528 2019-10-03 00:00:00 发表:<br>With editor已经三个月了,想撤稿</span>, beContent=130****6528 2019-10-03 00:00:00 发表: With editor已经三个月了,想撤稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17c95089935, createdName=145cf120m10(暂无昵称), createdTime=Tue Oct 08 00:00:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243217, encodeId=14cd224321ecb, content=偏重的研究方向:白血病<br>经验分享:投了两篇letter,2个月了还是显示with editor ,求教各位大神正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Wed Dec 18 06:28:28 CST 2024, time=2024-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241787, encodeId=43762241e8705, content=我的投稿从系统里消失了,前几天还好好的,已经送外审了,从昨天点进去一看根本找不到我的文章了,也没有任何被拒的痕迹或者邮件,而且好像springer nature下的各期刊都没有自己的主页,所以我找不到annals of hematology可以联系的邮箱,大家有遇到过这种情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f218759120, createdName=ms3000001014938846, createdTime=Wed Dec 11 09:58:30 CST 2024, time=2024-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2237488, encodeId=1155223e488ce, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:临床研究;移植预处理方案;前瞻,2期,单臂研究<br>经验分享:前期经过5次拒稿,我2024年1月14投稿Annals of hematology,2024年1月31编辑审核后送外审,2024年7月10日收到修改意见,2024年8月23收到文章被接受的消息,9月份线上发表,11月正式见刊,真的很开心,文章的顺利接受也带给我了信心,让我继续完成第二篇文章的创作,期待好的结果,也希望把这份好运气带给每一位投稿人,不管什么时候都不要放弃,你的文章一定会有属于它的一个家会接收它!加油,williamhill asia 都很棒!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/53b4a1217f3a4e079e3eaf104e804c09-leSA8mUKFk8P.jpg, createdBy=d5908847710, createdName=ms4000000203499871, createdTime=Sun Nov 17 22:09:53 CST 2024, time=2024-11-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183703, encodeId=792f2183e038c, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:投白血病相关的综述,2个审稿人,提的意见比较中肯,审稿速度很快<br>2023-11-23 投稿<br>2023-11-28 editor assigned<br>2023-11-29 Under Review<br>2023-12-12 Major revision<br>2023-12-26 Submitted to journal<br>2023-12-27 Under Review<br>2024-01-15 minor revision<br>2024-01-16 Submitted to journal<br>2024-01-19 Submission accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=775c5640894, createdName=ms8000000428100640, createdTime=Wed Jan 24 16:20:42 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;血液病<br>经验分享:根据投稿威廉亚洲博彩公司 要求修改排版,表达准确,图表清晰度够,审稿快,通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受 编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926986, encodeId=b5b192698693, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2020-09-04 投稿<br>2020-09-10 with editor<br>2020-10-02 Under Review<br>2020-11-11 Major Revision<br>2021-02-01 大修返回去<br>2021-02-02 with editor<br>2021-02-24 Accept<br>两个审稿人,大约提了20个问题,许多都是williamhill asia 当时刻意回避的,审稿人都提出来了,在大修中认真回答审稿人的问题,让做亚组分析就做亚组分析,不能补充的内容就实话实说,告知审稿人williamhill asia 的困难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLfmR4mafTv9yhHTykjCcGOQP5acHwbYj07fiaDoT6p8jxes2icO8n9R8BD8t0LJmg1SjlPiaqWZn33g/132, createdBy=5c971339316, createdName=bright120, createdTime=Wed Feb 24 23:39:35 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了,一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=)]
    2024-12-11 ms3000001014938846 来自天津

    我的投稿从系统里消失了,前几天还好好的,已经送外审了,从昨天点进去一看根本找不到我的文章了,也没有任何被拒的痕迹或者邮件,而且好像springer nature下的各期刊都没有自己的主页,所以我找不到annals of hematology可以联系的邮箱,大家有遇到过这种情况吗?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2197970, encodeId=2f3a219e970d7, content=质量检查就10天了,崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bbb4799156, createdName=2606467171, createdTime=Thu Apr 11 13:43:26 CST 2024, time=2024-04-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=577471, encodeId=68545e74718d, content=我也<span class="quote">130****6528 2019-10-03 00:00:00 发表:<br>With editor已经三个月了,想撤稿</span>, beContent=130****6528 2019-10-03 00:00:00 发表: With editor已经三个月了,想撤稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17c95089935, createdName=145cf120m10(暂无昵称), createdTime=Tue Oct 08 00:00:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243217, encodeId=14cd224321ecb, content=偏重的研究方向:白血病<br>经验分享:投了两篇letter,2个月了还是显示with editor ,求教各位大神正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Wed Dec 18 06:28:28 CST 2024, time=2024-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241787, encodeId=43762241e8705, content=我的投稿从系统里消失了,前几天还好好的,已经送外审了,从昨天点进去一看根本找不到我的文章了,也没有任何被拒的痕迹或者邮件,而且好像springer nature下的各期刊都没有自己的主页,所以我找不到annals of hematology可以联系的邮箱,大家有遇到过这种情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f218759120, createdName=ms3000001014938846, createdTime=Wed Dec 11 09:58:30 CST 2024, time=2024-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2237488, encodeId=1155223e488ce, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:临床研究;移植预处理方案;前瞻,2期,单臂研究<br>经验分享:前期经过5次拒稿,我2024年1月14投稿Annals of hematology,2024年1月31编辑审核后送外审,2024年7月10日收到修改意见,2024年8月23收到文章被接受的消息,9月份线上发表,11月正式见刊,真的很开心,文章的顺利接受也带给我了信心,让我继续完成第二篇文章的创作,期待好的结果,也希望把这份好运气带给每一位投稿人,不管什么时候都不要放弃,你的文章一定会有属于它的一个家会接收它!加油,williamhill asia 都很棒!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/53b4a1217f3a4e079e3eaf104e804c09-leSA8mUKFk8P.jpg, createdBy=d5908847710, createdName=ms4000000203499871, createdTime=Sun Nov 17 22:09:53 CST 2024, time=2024-11-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183703, encodeId=792f2183e038c, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:投白血病相关的综述,2个审稿人,提的意见比较中肯,审稿速度很快<br>2023-11-23 投稿<br>2023-11-28 editor assigned<br>2023-11-29 Under Review<br>2023-12-12 Major revision<br>2023-12-26 Submitted to journal<br>2023-12-27 Under Review<br>2024-01-15 minor revision<br>2024-01-16 Submitted to journal<br>2024-01-19 Submission accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=775c5640894, createdName=ms8000000428100640, createdTime=Wed Jan 24 16:20:42 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;血液病<br>经验分享:根据投稿威廉亚洲博彩公司 要求修改排版,表达准确,图表清晰度够,审稿快,通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受 编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926986, encodeId=b5b192698693, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2020-09-04 投稿<br>2020-09-10 with editor<br>2020-10-02 Under Review<br>2020-11-11 Major Revision<br>2021-02-01 大修返回去<br>2021-02-02 with editor<br>2021-02-24 Accept<br>两个审稿人,大约提了20个问题,许多都是williamhill asia 当时刻意回避的,审稿人都提出来了,在大修中认真回答审稿人的问题,让做亚组分析就做亚组分析,不能补充的内容就实话实说,告知审稿人williamhill asia 的困难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLfmR4mafTv9yhHTykjCcGOQP5acHwbYj07fiaDoT6p8jxes2icO8n9R8BD8t0LJmg1SjlPiaqWZn33g/132, createdBy=5c971339316, createdName=bright120, createdTime=Wed Feb 24 23:39:35 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了,一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=)]
    2024-11-17 ms4000000203499871 来自北京

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:临床研究;移植预处理方案;前瞻,2期,单臂研究
    经验分享:前期经过5次拒稿,我2024年1月14投稿Annals of hematology,2024年1月31编辑审核后送外审,2024年7月10日收到修改意见,2024年8月23收到文章被接受的消息,9月份线上发表,11月正式见刊,真的很开心,文章的顺利接受也带给我了信心,让我继续完成第二篇文章的创作,期待好的结果,也希望把这份好运气带给每一位投稿人,不管什么时候都不要放弃,你的文章一定会有属于它的一个家会接收它!加油,williamhill asia 都很棒!

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2197970, encodeId=2f3a219e970d7, content=质量检查就10天了,崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bbb4799156, createdName=2606467171, createdTime=Thu Apr 11 13:43:26 CST 2024, time=2024-04-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=577471, encodeId=68545e74718d, content=我也<span class="quote">130****6528 2019-10-03 00:00:00 发表:<br>With editor已经三个月了,想撤稿</span>, beContent=130****6528 2019-10-03 00:00:00 发表: With editor已经三个月了,想撤稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17c95089935, createdName=145cf120m10(暂无昵称), createdTime=Tue Oct 08 00:00:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243217, encodeId=14cd224321ecb, content=偏重的研究方向:白血病<br>经验分享:投了两篇letter,2个月了还是显示with editor ,求教各位大神正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Wed Dec 18 06:28:28 CST 2024, time=2024-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241787, encodeId=43762241e8705, content=我的投稿从系统里消失了,前几天还好好的,已经送外审了,从昨天点进去一看根本找不到我的文章了,也没有任何被拒的痕迹或者邮件,而且好像springer nature下的各期刊都没有自己的主页,所以我找不到annals of hematology可以联系的邮箱,大家有遇到过这种情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f218759120, createdName=ms3000001014938846, createdTime=Wed Dec 11 09:58:30 CST 2024, time=2024-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2237488, encodeId=1155223e488ce, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:临床研究;移植预处理方案;前瞻,2期,单臂研究<br>经验分享:前期经过5次拒稿,我2024年1月14投稿Annals of hematology,2024年1月31编辑审核后送外审,2024年7月10日收到修改意见,2024年8月23收到文章被接受的消息,9月份线上发表,11月正式见刊,真的很开心,文章的顺利接受也带给我了信心,让我继续完成第二篇文章的创作,期待好的结果,也希望把这份好运气带给每一位投稿人,不管什么时候都不要放弃,你的文章一定会有属于它的一个家会接收它!加油,williamhill asia 都很棒!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/53b4a1217f3a4e079e3eaf104e804c09-leSA8mUKFk8P.jpg, createdBy=d5908847710, createdName=ms4000000203499871, createdTime=Sun Nov 17 22:09:53 CST 2024, time=2024-11-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183703, encodeId=792f2183e038c, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:投白血病相关的综述,2个审稿人,提的意见比较中肯,审稿速度很快<br>2023-11-23 投稿<br>2023-11-28 editor assigned<br>2023-11-29 Under Review<br>2023-12-12 Major revision<br>2023-12-26 Submitted to journal<br>2023-12-27 Under Review<br>2024-01-15 minor revision<br>2024-01-16 Submitted to journal<br>2024-01-19 Submission accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=775c5640894, createdName=ms8000000428100640, createdTime=Wed Jan 24 16:20:42 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;血液病<br>经验分享:根据投稿威廉亚洲博彩公司 要求修改排版,表达准确,图表清晰度够,审稿快,通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受 编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926986, encodeId=b5b192698693, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2020-09-04 投稿<br>2020-09-10 with editor<br>2020-10-02 Under Review<br>2020-11-11 Major Revision<br>2021-02-01 大修返回去<br>2021-02-02 with editor<br>2021-02-24 Accept<br>两个审稿人,大约提了20个问题,许多都是williamhill asia 当时刻意回避的,审稿人都提出来了,在大修中认真回答审稿人的问题,让做亚组分析就做亚组分析,不能补充的内容就实话实说,告知审稿人williamhill asia 的困难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLfmR4mafTv9yhHTykjCcGOQP5acHwbYj07fiaDoT6p8jxes2icO8n9R8BD8t0LJmg1SjlPiaqWZn33g/132, createdBy=5c971339316, createdName=bright120, createdTime=Wed Feb 24 23:39:35 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了,一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=)]
    2024-01-24 ms8000000428100640 来自四川省

    审稿速度:2.0 | 投稿命中率:75.0
    经验分享:投白血病相关的综述,2个审稿人,提的意见比较中肯,审稿速度很快
    2023-11-23 投稿
    2023-11-28 editor assigned
    2023-11-29 Under Review
    2023-12-12 Major revision
    2023-12-26 Submitted to journal
    2023-12-27 Under Review
    2024-01-15 minor revision
    2024-01-16 Submitted to journal
    2024-01-19 Submission accepted

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2197970, encodeId=2f3a219e970d7, content=质量检查就10天了,崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bbb4799156, createdName=2606467171, createdTime=Thu Apr 11 13:43:26 CST 2024, time=2024-04-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=577471, encodeId=68545e74718d, content=我也<span class="quote">130****6528 2019-10-03 00:00:00 发表:<br>With editor已经三个月了,想撤稿</span>, beContent=130****6528 2019-10-03 00:00:00 发表: With editor已经三个月了,想撤稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17c95089935, createdName=145cf120m10(暂无昵称), createdTime=Tue Oct 08 00:00:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243217, encodeId=14cd224321ecb, content=偏重的研究方向:白血病<br>经验分享:投了两篇letter,2个月了还是显示with editor ,求教各位大神正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Wed Dec 18 06:28:28 CST 2024, time=2024-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241787, encodeId=43762241e8705, content=我的投稿从系统里消失了,前几天还好好的,已经送外审了,从昨天点进去一看根本找不到我的文章了,也没有任何被拒的痕迹或者邮件,而且好像springer nature下的各期刊都没有自己的主页,所以我找不到annals of hematology可以联系的邮箱,大家有遇到过这种情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f218759120, createdName=ms3000001014938846, createdTime=Wed Dec 11 09:58:30 CST 2024, time=2024-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2237488, encodeId=1155223e488ce, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:临床研究;移植预处理方案;前瞻,2期,单臂研究<br>经验分享:前期经过5次拒稿,我2024年1月14投稿Annals of hematology,2024年1月31编辑审核后送外审,2024年7月10日收到修改意见,2024年8月23收到文章被接受的消息,9月份线上发表,11月正式见刊,真的很开心,文章的顺利接受也带给我了信心,让我继续完成第二篇文章的创作,期待好的结果,也希望把这份好运气带给每一位投稿人,不管什么时候都不要放弃,你的文章一定会有属于它的一个家会接收它!加油,williamhill asia 都很棒!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/53b4a1217f3a4e079e3eaf104e804c09-leSA8mUKFk8P.jpg, createdBy=d5908847710, createdName=ms4000000203499871, createdTime=Sun Nov 17 22:09:53 CST 2024, time=2024-11-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183703, encodeId=792f2183e038c, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:投白血病相关的综述,2个审稿人,提的意见比较中肯,审稿速度很快<br>2023-11-23 投稿<br>2023-11-28 editor assigned<br>2023-11-29 Under Review<br>2023-12-12 Major revision<br>2023-12-26 Submitted to journal<br>2023-12-27 Under Review<br>2024-01-15 minor revision<br>2024-01-16 Submitted to journal<br>2024-01-19 Submission accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=775c5640894, createdName=ms8000000428100640, createdTime=Wed Jan 24 16:20:42 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;血液病<br>经验分享:根据投稿威廉亚洲博彩公司 要求修改排版,表达准确,图表清晰度够,审稿快,通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受 编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926986, encodeId=b5b192698693, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2020-09-04 投稿<br>2020-09-10 with editor<br>2020-10-02 Under Review<br>2020-11-11 Major Revision<br>2021-02-01 大修返回去<br>2021-02-02 with editor<br>2021-02-24 Accept<br>两个审稿人,大约提了20个问题,许多都是williamhill asia 当时刻意回避的,审稿人都提出来了,在大修中认真回答审稿人的问题,让做亚组分析就做亚组分析,不能补充的内容就实话实说,告知审稿人williamhill asia 的困难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLfmR4mafTv9yhHTykjCcGOQP5acHwbYj07fiaDoT6p8jxes2icO8n9R8BD8t0LJmg1SjlPiaqWZn33g/132, createdBy=5c971339316, createdName=bright120, createdTime=Wed Feb 24 23:39:35 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了,一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=)]
    2023-10-21 清清欢 来自江西省

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:肿瘤;血液病
    经验分享:根据投稿威廉亚洲博彩公司 要求修改排版,表达准确,图表清晰度够,审稿快,通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted

    4

    展开4条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2197970, encodeId=2f3a219e970d7, content=质量检查就10天了,崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bbb4799156, createdName=2606467171, createdTime=Thu Apr 11 13:43:26 CST 2024, time=2024-04-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=577471, encodeId=68545e74718d, content=我也<span class="quote">130****6528 2019-10-03 00:00:00 发表:<br>With editor已经三个月了,想撤稿</span>, beContent=130****6528 2019-10-03 00:00:00 发表: With editor已经三个月了,想撤稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17c95089935, createdName=145cf120m10(暂无昵称), createdTime=Tue Oct 08 00:00:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243217, encodeId=14cd224321ecb, content=偏重的研究方向:白血病<br>经验分享:投了两篇letter,2个月了还是显示with editor ,求教各位大神正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Wed Dec 18 06:28:28 CST 2024, time=2024-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241787, encodeId=43762241e8705, content=我的投稿从系统里消失了,前几天还好好的,已经送外审了,从昨天点进去一看根本找不到我的文章了,也没有任何被拒的痕迹或者邮件,而且好像springer nature下的各期刊都没有自己的主页,所以我找不到annals of hematology可以联系的邮箱,大家有遇到过这种情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f218759120, createdName=ms3000001014938846, createdTime=Wed Dec 11 09:58:30 CST 2024, time=2024-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2237488, encodeId=1155223e488ce, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:临床研究;移植预处理方案;前瞻,2期,单臂研究<br>经验分享:前期经过5次拒稿,我2024年1月14投稿Annals of hematology,2024年1月31编辑审核后送外审,2024年7月10日收到修改意见,2024年8月23收到文章被接受的消息,9月份线上发表,11月正式见刊,真的很开心,文章的顺利接受也带给我了信心,让我继续完成第二篇文章的创作,期待好的结果,也希望把这份好运气带给每一位投稿人,不管什么时候都不要放弃,你的文章一定会有属于它的一个家会接收它!加油,williamhill asia 都很棒!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/53b4a1217f3a4e079e3eaf104e804c09-leSA8mUKFk8P.jpg, createdBy=d5908847710, createdName=ms4000000203499871, createdTime=Sun Nov 17 22:09:53 CST 2024, time=2024-11-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183703, encodeId=792f2183e038c, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:投白血病相关的综述,2个审稿人,提的意见比较中肯,审稿速度很快<br>2023-11-23 投稿<br>2023-11-28 editor assigned<br>2023-11-29 Under Review<br>2023-12-12 Major revision<br>2023-12-26 Submitted to journal<br>2023-12-27 Under Review<br>2024-01-15 minor revision<br>2024-01-16 Submitted to journal<br>2024-01-19 Submission accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=775c5640894, createdName=ms8000000428100640, createdTime=Wed Jan 24 16:20:42 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;血液病<br>经验分享:根据投稿威廉亚洲博彩公司 要求修改排版,表达准确,图表清晰度够,审稿快,通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受 编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926986, encodeId=b5b192698693, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2020-09-04 投稿<br>2020-09-10 with editor<br>2020-10-02 Under Review<br>2020-11-11 Major Revision<br>2021-02-01 大修返回去<br>2021-02-02 with editor<br>2021-02-24 Accept<br>两个审稿人,大约提了20个问题,许多都是williamhill asia 当时刻意回避的,审稿人都提出来了,在大修中认真回答审稿人的问题,让做亚组分析就做亚组分析,不能补充的内容就实话实说,告知审稿人williamhill asia 的困难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLfmR4mafTv9yhHTykjCcGOQP5acHwbYj07fiaDoT6p8jxes2icO8n9R8BD8t0LJmg1SjlPiaqWZn33g/132, createdBy=5c971339316, createdName=bright120, createdTime=Wed Feb 24 23:39:35 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了,一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=)]
    2023-04-13 凶巴巴恰北北怪兽

    2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受 编辑很客气

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2197970, encodeId=2f3a219e970d7, content=质量检查就10天了,崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bbb4799156, createdName=2606467171, createdTime=Thu Apr 11 13:43:26 CST 2024, time=2024-04-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=577471, encodeId=68545e74718d, content=我也<span class="quote">130****6528 2019-10-03 00:00:00 发表:<br>With editor已经三个月了,想撤稿</span>, beContent=130****6528 2019-10-03 00:00:00 发表: With editor已经三个月了,想撤稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17c95089935, createdName=145cf120m10(暂无昵称), createdTime=Tue Oct 08 00:00:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243217, encodeId=14cd224321ecb, content=偏重的研究方向:白血病<br>经验分享:投了两篇letter,2个月了还是显示with editor ,求教各位大神正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Wed Dec 18 06:28:28 CST 2024, time=2024-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241787, encodeId=43762241e8705, content=我的投稿从系统里消失了,前几天还好好的,已经送外审了,从昨天点进去一看根本找不到我的文章了,也没有任何被拒的痕迹或者邮件,而且好像springer nature下的各期刊都没有自己的主页,所以我找不到annals of hematology可以联系的邮箱,大家有遇到过这种情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f218759120, createdName=ms3000001014938846, createdTime=Wed Dec 11 09:58:30 CST 2024, time=2024-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2237488, encodeId=1155223e488ce, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:临床研究;移植预处理方案;前瞻,2期,单臂研究<br>经验分享:前期经过5次拒稿,我2024年1月14投稿Annals of hematology,2024年1月31编辑审核后送外审,2024年7月10日收到修改意见,2024年8月23收到文章被接受的消息,9月份线上发表,11月正式见刊,真的很开心,文章的顺利接受也带给我了信心,让我继续完成第二篇文章的创作,期待好的结果,也希望把这份好运气带给每一位投稿人,不管什么时候都不要放弃,你的文章一定会有属于它的一个家会接收它!加油,williamhill asia 都很棒!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/53b4a1217f3a4e079e3eaf104e804c09-leSA8mUKFk8P.jpg, createdBy=d5908847710, createdName=ms4000000203499871, createdTime=Sun Nov 17 22:09:53 CST 2024, time=2024-11-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183703, encodeId=792f2183e038c, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:投白血病相关的综述,2个审稿人,提的意见比较中肯,审稿速度很快<br>2023-11-23 投稿<br>2023-11-28 editor assigned<br>2023-11-29 Under Review<br>2023-12-12 Major revision<br>2023-12-26 Submitted to journal<br>2023-12-27 Under Review<br>2024-01-15 minor revision<br>2024-01-16 Submitted to journal<br>2024-01-19 Submission accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=775c5640894, createdName=ms8000000428100640, createdTime=Wed Jan 24 16:20:42 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;血液病<br>经验分享:根据投稿威廉亚洲博彩公司 要求修改排版,表达准确,图表清晰度够,审稿快,通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受 编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926986, encodeId=b5b192698693, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2020-09-04 投稿<br>2020-09-10 with editor<br>2020-10-02 Under Review<br>2020-11-11 Major Revision<br>2021-02-01 大修返回去<br>2021-02-02 with editor<br>2021-02-24 Accept<br>两个审稿人,大约提了20个问题,许多都是williamhill asia 当时刻意回避的,审稿人都提出来了,在大修中认真回答审稿人的问题,让做亚组分析就做亚组分析,不能补充的内容就实话实说,告知审稿人williamhill asia 的困难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLfmR4mafTv9yhHTykjCcGOQP5acHwbYj07fiaDoT6p8jxes2icO8n9R8BD8t0LJmg1SjlPiaqWZn33g/132, createdBy=5c971339316, createdName=bright120, createdTime=Wed Feb 24 23:39:35 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了,一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=)]
    2021-02-24 bright120

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:2020-09-04 投稿
    2020-09-10 with editor
    2020-10-02 Under Review
    2020-11-11 Major Revision
    2021-02-01 大修返回去
    2021-02-02 with editor
    2021-02-24 Accept
    两个审稿人,大约提了20个问题,许多都是williamhill asia 当时刻意回避的,审稿人都提出来了,在大修中认真回答审稿人的问题,让做亚组分析就做亚组分析,不能补充的内容就实话实说,告知审稿人williamhill asia 的困难。

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2197970, encodeId=2f3a219e970d7, content=质量检查就10天了,崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bbb4799156, createdName=2606467171, createdTime=Thu Apr 11 13:43:26 CST 2024, time=2024-04-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=577471, encodeId=68545e74718d, content=我也<span class="quote">130****6528 2019-10-03 00:00:00 发表:<br>With editor已经三个月了,想撤稿</span>, beContent=130****6528 2019-10-03 00:00:00 发表: With editor已经三个月了,想撤稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17c95089935, createdName=145cf120m10(暂无昵称), createdTime=Tue Oct 08 00:00:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243217, encodeId=14cd224321ecb, content=偏重的研究方向:白血病<br>经验分享:投了两篇letter,2个月了还是显示with editor ,求教各位大神正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Wed Dec 18 06:28:28 CST 2024, time=2024-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241787, encodeId=43762241e8705, content=我的投稿从系统里消失了,前几天还好好的,已经送外审了,从昨天点进去一看根本找不到我的文章了,也没有任何被拒的痕迹或者邮件,而且好像springer nature下的各期刊都没有自己的主页,所以我找不到annals of hematology可以联系的邮箱,大家有遇到过这种情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f218759120, createdName=ms3000001014938846, createdTime=Wed Dec 11 09:58:30 CST 2024, time=2024-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2237488, encodeId=1155223e488ce, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:临床研究;移植预处理方案;前瞻,2期,单臂研究<br>经验分享:前期经过5次拒稿,我2024年1月14投稿Annals of hematology,2024年1月31编辑审核后送外审,2024年7月10日收到修改意见,2024年8月23收到文章被接受的消息,9月份线上发表,11月正式见刊,真的很开心,文章的顺利接受也带给我了信心,让我继续完成第二篇文章的创作,期待好的结果,也希望把这份好运气带给每一位投稿人,不管什么时候都不要放弃,你的文章一定会有属于它的一个家会接收它!加油,williamhill asia 都很棒!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/53b4a1217f3a4e079e3eaf104e804c09-leSA8mUKFk8P.jpg, createdBy=d5908847710, createdName=ms4000000203499871, createdTime=Sun Nov 17 22:09:53 CST 2024, time=2024-11-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183703, encodeId=792f2183e038c, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:投白血病相关的综述,2个审稿人,提的意见比较中肯,审稿速度很快<br>2023-11-23 投稿<br>2023-11-28 editor assigned<br>2023-11-29 Under Review<br>2023-12-12 Major revision<br>2023-12-26 Submitted to journal<br>2023-12-27 Under Review<br>2024-01-15 minor revision<br>2024-01-16 Submitted to journal<br>2024-01-19 Submission accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=775c5640894, createdName=ms8000000428100640, createdTime=Wed Jan 24 16:20:42 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;血液病<br>经验分享:根据投稿威廉亚洲博彩公司 要求修改排版,表达准确,图表清晰度够,审稿快,通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受 编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926986, encodeId=b5b192698693, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2020-09-04 投稿<br>2020-09-10 with editor<br>2020-10-02 Under Review<br>2020-11-11 Major Revision<br>2021-02-01 大修返回去<br>2021-02-02 with editor<br>2021-02-24 Accept<br>两个审稿人,大约提了20个问题,许多都是williamhill asia 当时刻意回避的,审稿人都提出来了,在大修中认真回答审稿人的问题,让做亚组分析就做亚组分析,不能补充的内容就实话实说,告知审稿人williamhill asia 的困难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLfmR4mafTv9yhHTykjCcGOQP5acHwbYj07fiaDoT6p8jxes2icO8n9R8BD8t0LJmg1SjlPiaqWZn33g/132, createdBy=5c971339316, createdName=bright120, createdTime=Wed Feb 24 23:39:35 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了,一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=)]
    2019-08-13 122e6881m72暂无昵称

    三个月了,一审还在under review。。。

    1

    展开1条回复
共146条页码: 1/15页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分